Founded in 2011, Beijing Adcanced Medical Technologles,Led.Inc. is a high-tech enterprise founded by returned overseas students. The company's headquarters is located in the core area of Zhongguancun Science and Technology Park where talents gather - Zhongguancun Biomedical Park. The registered capital is 22 million.
Beijing Amet Corporation is a company that uses 3D precision printing technology to develop and produce fully absorbable coronary stents and peripheral stents. The company has the patented technology of 3D rapid vascular stent manufacturing and complete independent intellectual property rights. This technology is completely different from the laser cutting technology used by foreign companies such as Abbott. It has the characteristics of high speed, high yield and good mechanical properties of products. Therefore, this innovative technology has incomparable advantages over the traditional laser cutting method to manufacture degradable stents. This major breakthrough in innovative stent manufacturing technology will enable China's 3D precision printing technology to go international. Will revolutionize the manufacture and use of cardiovascular stents
Beijing Amet has a professional, innovative and global talent team composed of experts, professors, doctors and masters. Among them are 3 Beijing Haiju engineering talents and 1 Gaoju engineering talent. The company also has an expert committee composed of world-renowned experts and professors. At present, Amet has established a close scientific research cooperation relationship with many well-known universities and scientific research institutions at home and abroad.
Beijing Amet has strong technological innovation and product development capabilities. It has undertaken the 13th Five-Year Support Program of the Ministry of Science and Technology, the Beijing Science and Technology Commission's strategic emerging industry cultivation project, and the Zhongguancun Management Committee's Haidian Garden SME innovation project.
Relying on its core 3D precision printing technology, Beijing Amet will continue to expand its application fields, and devote itself to the development and production of endovascular implantation and interventional products with excellent performance, so as to build Amet into an international excellent medical device company.